SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 72 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $123,000 | -20.6% | 226,190 | -21.4% | 0.00% | – |
| Q1 2016 | $155,000 | -50.0% | 287,607 | -17.0% | 0.00% | – |
| Q4 2015 | $310,000 | -49.8% | 346,601 | -54.6% | 0.00% | – |
| Q3 2015 | $618,000 | -83.1% | 762,608 | -37.4% | 0.00% | -100.0% |
| Q2 2015 | $3,664,000 | -15.9% | 1,217,380 | -31.5% | 0.00% | -50.0% |
| Q1 2015 | $4,356,000 | +298.9% | 1,777,488 | +315.1% | 0.00% | – |
| Q4 2014 | $1,092,000 | -90.6% | 428,201 | -73.7% | 0.00% | -100.0% |
| Q3 2014 | $11,606,000 | +71.5% | 1,625,500 | +56.6% | 0.00% | +33.3% |
| Q2 2014 | $6,766,000 | +22.1% | 1,037,734 | +23.8% | 0.00% | 0.0% |
| Q1 2014 | $5,542,000 | +804.1% | 838,400 | +548.1% | 0.00% | – |
| Q4 2013 | $613,000 | -23.1% | 129,358 | -15.5% | 0.00% | – |
| Q2 2013 | $797,000 | – | 153,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 8,250,000 | $7,404,000 | 3.11% |
| BVF INC/IL | 4,777,381 | $4,288,000 | 0.73% |
| NEA Management Company, LLC | 7,789,644 | $7,011,000 | 0.45% |
| Palo Alto Investors LP | 6,974,854 | $6,260,000 | 0.35% |
| Healthcare Value Capital, LLC | 150,000 | $135,000 | 0.22% |
| Frontier Wealth Management LLC | 527,870 | $474,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,067,122 | $1,855,000 | 0.06% |
| Baker Brothers Advisors | 4,450,000 | $3,994,000 | 0.03% |
| Noven Financial Group, Inc. | 41,000 | $37,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 100,000 | $90,000 | 0.02% |